Rappaport Reiches Capital Management, LLC Adaptive Biotechnologies Corp Transaction History
Rappaport Reiches Capital Management, LLC
- $339 Billion
- Q2 2024
A detailed history of Rappaport Reiches Capital Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rappaport Reiches Capital Management, LLC holds 68,080 shares of ADPT stock, worth $375,801. This represents 0.07% of its overall portfolio holdings.
Number of Shares
68,080
Previous 68,080
-0.0%
Holding current value
$375,801
Previous $219 Million
12.77%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
187Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$166 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$77.3 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$64.4 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$63.9 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$63 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $789M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...